The Role of Metabolic and Environmental Factors in the Formation of Advanced Glycation End Products
Author:
- 19 December 2025
- journal article
- Published by Bandirma Onyedi Eylul Universitesi Saglik Bilimleri ve Arastirmalari Dergisi in Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi
- Vol. 7 (3) , 986-997
Abstract
Advanced glycation end products (AGEs) are detrimental compounds formed through the non-enzymatic glycation and oxidation of proteins, lipids, and nucleic acids. Their accumulation, influenced by factors such as hyperglycemia, aging, obesity, chronic kidney disease, and inflammatory processes, poses significant health risks. Hyperglycemia, prevalent in diabetes, accelerates the formation of these compounds due to elevated levels of reactive dicarbonyls, including methylglyoxal. Aging contributes to the buildup of these products, potentially accelerating age-related physiological decline. Obesity exacerbates their accumulation through increased oxidative stress and insulin resistance. Environmental factors, such as dietary habits, cooking methods, and lifestyle choices, play crucial roles in the formation of these compounds. Protein- and fat-rich foods subjected to high temperatures tend to have higher concentrations of these harmful compounds. Foods rich in proteins and fats, particularly when subjected to high temperatures, exhibit higher concentrations of these harmful compounds. Lifestyle factors, including physical inactivity and smoking, further elevate their levels; conversely, regular physical activity is associated with lower concentrations. The aim of this review is to elucidate the factors influencing the formation of Advanced glycation end products and to identify strategies to reduce their adverse health effects.Keywords
This publication has 71 references indexed in Scilit:
- Differences in kinetics and dynamics of endogenous versus exogenous advanced glycation end products (AGEs) and their precursorsFood and Chemical Toxicology, 2022
- The Role of Dietary Advanced Glycation End Products in Metabolic DysfunctionMolecular Nutrition & Food Research, 2020
- Advanced glycation end-products in morbid obesity and after bariatric surgery: When glycemic memory starts to failEndocrinología, Diabetes y Nutrición (English Ed.), 2017
- Targeting advanced glycation with pharmaceutical agents: where are we now?Glycoconjugate Journal, 2016
- Advanced glycation End-products (AGEs): an emerging concern for processed food industriesJournal of Food Science and Technology, 2015
- The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: A randomized factorial design trialExperimental Gerontology, 2013
- Glyoxalase 1 and glyoxalase 2 activities in blood and neuronal tissue samples from experimental animal models of obesity and type 2 diabetes mellitusThe Journal of Physiological Sciences, 2012
- Advanced glycation endproducts—role in pathology of diabetic complicationsDiabetes Research and Clinical Practice, 2005
- Presence of Diabetic Complications in Type 1 Diabetic Patients Correlates with Low Expression of Mononuclear Cell AGE-Receptor-1 and Elevated Serum AGEMolecular Medicine, 2001
- Identification of Galectin-3 As a High-Affinity Binding Protein for Advanced Glycation End Products (AGE): A New Member of the AGE-Receptor ComplexMolecular Medicine, 1995